Professor Lisa Maher
Contact Details
image - LM Work Photo
Scientific Advisory Board (SAB)

Lisa Maher holds appointments as a Professor in the Faculty of Medicine at the University of New South Wales in Sydney, Australia, Program Head at the Kirby Institute for infection and immunity and National Health and Medical Research Council (NHMRC) Senior Research Fellow. She has extensive experience in research, program development and service delivery with drug users, sex workers and people living with HIV in North America, South East Asia, Australia and the Pacific. Her research focuses on the prevention of infectious disease in vulnerable populations and she currently leads a randomised controlled trial of hepatitis B vaccine completion in people who inject drugs and a program of hepatitis C vaccine preparedness studies, including a cohort of anti-HCV negative people who inject drugs. She is an investigator on longitudinal studies of drug users and female sex workers in Canada, female sex workers in Cambodia, and an international collaboration of cohorts examining acute HIV and HCV infection in people who inject drugs and two large community randomised prevention trials. Professor Maher is also responsible for a national program of viral hepatitis surveillance, including Australia’s internationally renowned system for monitoring anti-HIV and anti-HCV prevalence and associated risk behaviour in people who inject drugs.